How to prevent nanosilver and carbon nanotubes from becoming toxic to organisms, especially from harming the body when they enter the blood, lungs or other sensitive parts?
Surface Coating: Coating nanosilver particles with biocompatible materials can reduce their toxicity.
Size Control: Smaller particles are more likely to be toxic, so controlling particle size can help mitigate risks.
Stabilization: Using stabilizing agents to prevent aggregation can reduce the likelihood of toxic effects.
For Carbon Nanotubes:
Surface Functionalization: Modifying the surface of CNTs with functional groups can mitigate adverse biological responses.
Purity and Consistency: Ensuring the purity and consistency of raw materials used in CNT synthesis can prevent toxicity due to contaminants and surface defects.
Aspect Ratio Control: Restricting the use of CNTs with high aspect ratios, as long CNTs can have asbestos-like pathogenicity, which can be alleviated by chemical modification or shortening.
Also, check for cytotoxicity of the synthesized material via computation and invitro, vivo studies for further clarifications.